Targeting mutant p53 shows promise for sunscreens and skin cancer

Journal of Clinical Investigation

Volumn 117, Issue 12, 2007, Pages 3658-3660

  El Deiry, Wafik S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 DIMETHYLAMINOPROPYLAMINO) 2 (4 METHOXYSTYRYL)QUINAZOLINE; CYCLOSPORIN; FLUOROURACIL; IMIQUIMOD; MUTANT PROTEIN; PROTEIN P53; SUNSCREEN;

CARCINOMA CELL; CHEMOPROPHYLAXIS; DRUG ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; GENE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; REVIEW; SKIN CANCER; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET B RADIATION;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CASPASE 3; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CYCLINS; CYTOCHROMES C; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MICE; MICE, INBRED HRS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MUTATION; NEOPLASMS, RADIATION-INDUCED; POLY(ADP-RIBOSE) POLYMERASES; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN TRANSPORT; PYRIMIDINES; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 36849006530     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI34251     Document Type: Review

References (20)

1. American Cancer Society. 2007. Skin cancer facts. http://www.cancer.org/ docroot/PED/content/ped_7_1_What_You_Need_To_Know_About_Skin_Cancer.asp? sitearea=PED.
2. Abdulla, F.R., Feldman, S.R., Williford, S.R., Krowchuk, D., and Kaur, M. 2005.Tanning and skin cancer. Pediatr. Dermatol. 22:501-512.
3. Brash, D.E., et al. 1991. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. U. S. A. 88:10124-10128.
4. Queille, S., et al. 2007. Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene. Carcinogenesis. 28:724-731.
5. Rady, P., Scinicariello, F., Wagner, R.F., Jr., and Tyring, S.K. 1992. p53 mutations in basal cell carcinomas. Cancer Res. 52:3804-3806.
6. Bolshakov, S., et al. 2003. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Clin. Cancer Res. 9:228-234.
7. Aszterbaum, M., et al. 1999. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat. Med. 5:1285-1291.
8. Marx, J. 2007. Recruiting the cell's own guardian for cancer therapy. Science. 315:1211-1213.
9. Velculescu, V.E., and El-Deiry, W.S. 1996. Biological and clinical importance of the p53 tumor suppressor gene. Clin. Chem. 42:858-868.
10. Ananthaswamy, H.N., et al. 1997. Sunlight and skin cancer: inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens. Nat. Med. 3:510-514.
11. Jensen, E.H., Margolin, K.A., and Sondak, V.K. 2005. Melanoma and other skin cancers. In Cancer management: a multidisciplinary approach. R. Pazdur, L.R. Coia, W.J. Hoskins, and L.D. Wagman, editors. 9th edition. CMP Healthcare Media. San Francisco, California, USA. 531-561.
12. Neville, J.A., Welch, E., and Leffell, D.J. 2007. Management of nonmelanoma skin cancer in 2007. Nat. Clin. Pract. Oncol. 4:462-469.
13. Foster, B.A., Coffey, H.A., Morin, M.J., and Rastinejad, F. 1999. Pharmacological rescue of mutant p53 conformation and function. Science. 286:2507-2510.
14. Wang, W., Takimoto, R., Rastinejad, F., and El-Deiry, W.S. 2003. Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding. Mol. Cell. Biol. 23:2171-2181.
15. Takimoto, R., et al. 2002. The mutant p53-conformation modifying drug, CP-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 protein. Cancer Biol. Ther. 1:47-55.
16. Rippin, T.M., et al. 2002. Characterization of the p53-rescue drug CP-31398 in vitro and in living cells. Oncogene. 21:2119-2129.
17. Tang, X., et al. 2007. CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice. J. Clin. Invest. 117:3753-3764.
18. Christophorou, M.A., et al. 2006. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature. 443:214-217.
19. Smalley, K.S., et al. 2007. An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells. Cancer Res. 67:209-217.
20. Talalay, P., et al. 2007. Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation. Proc. Natl. Acad. Sci. U. S. A. 104:17500-17505.